Streptococcal immunoglobulin-binding protein Sib35 exerts stimulatory and mitogenic effects toward mouse B lymphocytes

FEMS Microbiology Letters

Volumn 281, Issue 1, 2008, Pages 73-80

  Okamoto, Shigefumi ^b   Terao, Yutaka ^a   Tamura, Yasuharu ^a   Hamada, Shigeyuki ^c   Kawabata, Shigetada ^a  

^a OSAKA UNIVERSITY   (Japan)

^b NATIONAL INSTITUTE OF BIOMEDICAL INNOVATION   (Japan)

^c NIHON UNIVERSITY   (Japan)

Author keywords

B cell mitogen; Sib35; Streptococcus pyogenes

Indexed keywords

BACTERIAL PROTEIN; BINDING PROTEIN; CD86 ANTIGEN; IMMUNOGLOBULIN BINDING PROTEIN; IMMUNOGLOBULIN BINDING PROTEIN 35; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; UNCLASSIFIED DRUG;

ANIMAL CELL; ANTIGEN EXPRESSION; ARTICLE; B LYMPHOCYTE; B LYMPHOCYTE ACTIVATION; B LYMPHOCYTE DIFFERENTIATION; CONTROLLED STUDY; FEMALE; IMMUNOMODULATION; LYMPHOCYTE PROLIFERATION; MITOGENICITY; MOUSE; NONHUMAN; PLASMA CELL; PRIORITY JOURNAL; SPLEEN CELL; STREPTOCOCCUS PYOGENES; T LYMPHOCYTE;

STREPTOCOCCUS PYOGENES; STREPTOCOCCUS SP. 'GROUP A';

EID: 40349087551     PISSN: 03781097     EISSN: 15746968     Source Type: Journal    
DOI: 10.1111/j.1574-6968.2008.01078.x     Document Type: Article

References (23)

1. Äkesson P, Cooney J, Kishimoto F & Björck L (1990) Protein H–a novel IgG binding bacterial protein. Mol Immunol 27: 523–531.
2. Arimura Y, Ogimoto M, Mitomo K et al. (2001) CD45 is required for CD40‐induced inhibition of DNA synthesis and regulation of c‐Jun NH 2 ‐terminal kinase and p38 in BAL‐17 B cells. J Biol Chem 276: 8550–8556.
3. Baxter F & McChesney J (2000) Severe group A streptococcal infection and streptococcal toxic shock syndrome. Can J Anaesth 47: 1129–1140.
4. Castigli E, Alt FW, Davidson L, Bottaro A, Mizoguchi E, Bhan AK & Geha RS (1994) CD40‐deficient mice generated by recombination‐activating gene‐2‐deficient blastocyst complementation. Proc Natl Acad Sci USA 91: 12135–12139.
5. Cunningham MW (2000) Pathogenesis of group A streptococcal infections. Clin Microbiol Rev 13: 470–511.
6. Hamada S, Yamamoto T, Koga T, McGhee JR, Michalek SM & Yamamoto S (1985) Chemical properties and immunobiological activities of streptococcal lipoteichoic acids. Zentralbl Bakteriol Mikrobiol Hyg [A] 259: 228–243.
7. Kawabata S, Tamura Y, Murakami J, Terao Y, Nakagawa I & Hamada S (2002) A novel, anchorless streptococcal surface protein that binds to human immunoglobulins. Biochem Biophys Res Commun 296: 1329–1333.
8. Lei B, DeLeo FR, Hoe NP et al. (2001) Evasion of human innate and acquired immunity by a bacterial homolog of CD11b that inhibits opsonophagocytosis. Nat Med 7: 1298–1305.
9. Lindahl G & Äkerstrom B (1989) Receptor for IgA in group A streptococci: cloning of the gene and characterization of the protein expressed in Escherichia coli. Mol Microbiol 3: 239–247.
10. Medina E, Talay SR, Chhatwal GS & Guzmán CA (1998) Fibronectin‐binding protein I of Streptococcus pyogenes promotes T cell‐independent proliferation of murine B lymphocytes and enhances the expression of MHC class II molecules on antigen‐presenting cells. Intl Immunol 10: 1657–1664.
11. Mey A & Revillard JP (1998) Mitogenic response of murine B lymphocytes to Salmonella typhimurium lipopolysaccharide requires protein kinase C‐dependent late tyrosine phosphorylations. Infect Immun 66: 2547–2552.
12. Navarre WW & Schneewind O (1999) Surface proteins of gram‐positive bacteria and mechanisms of their targeting to the cell wall envelope. Microbiol Mol Biol Rev 63: 174–229.
13. Okamoto S, Azhipa O, Yu Y, Russo E & Dennert G (1998) Expression of ADP‐ribosyltransferase on normal T lymphocytes and effects of nicotinamide adenine dinucleotide on their function. J Immunol 160: 4190–4198.
14. Okamoto S, Kawabata S, Nakagawa I & Hamada S (2001) Administration of superantigens protects mice from lethal Listeria monocytogenes infection by enhancing cytotoxic T cells. Infect Immun 69: 6633–6642.
15. Okamoto S, Tamura Y, Terao Y, Hamada S & Kawabata S (2005) Systemic immunization with streptococcal immunoglobulin‐binding protein Sib 35 induces protective immunity against group: a Streptococcus challenge in mice. Vaccine 23: 4852–4859.
16. Proft T, Moffatt SL, Berkahn CJ & Fraser JD (1999) Identification and characterization of novel superantigens from Streptococcus pyogenes. J Exp Med 189: 89–102.
17. Randall TD, Heath AW, Santos‐Argumedo L, Howard MC, Weissman IL & Lund FE (1998) Arrest of B lymphocyte terminal differentiation by CD40 signaling: mechanism for lack of antibody-secreting cells in germinal centers. Immunity 8: 733–742.
18. Takeuchi O, Hoshino K, Kawai T et al. (1999) Differential roles of TLR2 and TLR4 in recognition of gram‐negative and gram‐positive bacterial cell wall components. Immunity 11: 443–451.
19. Terao Y, Kawabata S, Kunitomo E, Murakami J, Nakagawa I & Hamada S (2001) Fba, a novel fibronectin‐binding protein from Streptococcus pyogenes, promotes bacterial entry into epithelial cells, and the fba gene is positively transcribed under the Mga regulator. Mol Microbiol 42: 75–86.
20. Terao Y, Kawabata S, Nakata M, Nakagawa I & Hamada S (2002) Molecular characterization of a novel fibronectin‐binding protein of Streptococcus pyogenes strains isolated from toxic shock‐like syndrome patients. J Biol Chem 277: 47428–47435.
21. Toyosaki T, Yoshioka T, Tsuruta Y, Yutsudo T, Iwasaki M & Suzuki R (1996) Definition of the mitogenic factor (MF) as a novel streptococcal superantigen that is different from streptococcal pyrogenic exotoxins A, B, and C. Eur J Immunol 26: 2693–2701.
22. Tseng J, Eisfelder BJ & Clark MR (1997) B‐cell antigen receptor‐induced apoptosis requires both Ig alpha and Ig beta. Blood 89: 1513–1520.
23. Von Pawel‐Rammingen U, Johansson BP, Tapper H & Björck L (2002) Streptococcus pyogenes and phagocytic killing. Nat Med 8: 1044–1045 ; author reply 1045–1046.